MOMETASONE Drug Patent Profile

When do Mometasone patents expire, and when can generic versions of Mometasone launch?

Mometasone is a drug marketed by Chartwell Molecular, Cosette, Fougera Pharms, Glenmark Pharms, Sun Pharma Canada, Encube, Glenmark Pharms Ltd, Padagis Israel, Padagis Us, Torrent, Amneal, Amneal Pharms, Apotex, Aurobindo Pharma, and Naspress. and is included in twenty-five NDAs.

The generic ingredient in MOMETASONE is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Mometasone

A generic version of MOMETASONE was approved as mometasone furoate by PADAGIS US on March 18^th, 2002.

Summary for MOMETASONE

US Patents:	0
Applicants:	15
NDAs:	25
Drug Prices:	Drug price information for MOMETASONE
Drug Sales Revenues:	Drug sales revenues for MOMETASONE
DailyMed Link:	MOMETASONE at DailyMed

See drug prices for MOMETASONE

See drug sales revenues for MOMETASONE

US Patents and Regulatory Information for MOMETASONE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecular	MOMETASONE FUROATE	mometasone furoate	CREAM;TOPICAL	076591-001	Apr 18, 2007		DISCN	No	No
Torrent	MOMETASONE FUROATE	mometasone furoate	OINTMENT;TOPICAL	207899-001	Jul 13, 2018	AB	RX	No	No
Aurobindo Pharma	MOMETASONE FUROATE	mometasone furoate	SPRAY, METERED;NASAL	217498-001	Nov 22, 2024		DISCN	No	No
Encube	MOMETASONE FUROATE	mometasone furoate	LOTION;TOPICAL	076499-001	Nov 21, 2007	AB	RX	No	No
Glenmark Pharms	MOMETASONE FUROATE	mometasone furoate	CREAM;TOPICAL	078541-001	May 28, 2008		DISCN	No	No
Cosette	MOMETASONE FUROATE	mometasone furoate	OINTMENT;TOPICAL	077401-001	Jun 20, 2006	AB	RX	No	No
Amneal Pharms	MOMETASONE FUROATE	mometasone furoate	SPRAY, METERED;NASAL	207989-001	Apr 3, 2017	AB	RX	No	No